Zimmer Biomet Shares Jump After Q2 Results and Analyst Upgrade
Zimmer Biomet stock rose sharply in pre-market trading after the company posted second-quarter 2026 results that topped modest Street expectations. The report, combined with a recent high-profile analyst upgrade and positive results from sector peers, contributed to the move toward the $100 level and narrowed the gap to the 52-week high.